Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1170-1177

  Flanagan, Diana Lowery ^a   Jennings, C Darrell ^a   Bryson, J Scott ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; GRAFT VERSUS HOST REACTION; HELPER CELL; ISOGRAFT; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; WEIGHT REDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, SURFACE; COLON; CYCLOSPORINE; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; GRAFT VS HOST DISEASE; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-12; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; PROTEINS; RNA, MESSENGER; TH1 CELLS; TRANSPLANTATION, ISOGENEIC;

EID: 0033179272     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Glazier, A., P. J. Tutschka, E. R. Farmer, and G. W. Santos. 1983. Graft-versus-host disease in cyclosporine-A treated rats after syngeneic and autologous bone marrow transplantation and cyclosporine treatment. J. Exp. Med. 158:1.
2. Jones, R. J., A. D. Hess, R. B. Mann, S. Piantadosi, G. B. Vogelsang, E. R. Farmer, R. B. Geller, and G. W. Santos. 1989. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1:754.
3. Talbot, D. C., R. Powles, J. P. Sloane, J. Rose, J. Treleaven, H. Aboud, G. Helenglass, P. Parikh, C. Smith, M. Rowley, J. Cavanagh, S. Milliken, M. Hewetson, and J. Norton. 1990. Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukemia. Bone Marrow Transplant. 6:17.
4. Carella, A. M., E. Gaozza, A. Congiu, P. Carlier, S. Nati, M. Truini, A. Castellaneta, and M. Viale. 1991. Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies. Ann. Hematol. 62:156.
5. Yeager, A. M., G. B. Vogelsang, R. J. Jones, E. R. Farmer, V. Altomonte, A. D. Hess, and G. W. Santos. 1992. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia. Blood 79:3031.
6. Kennedy, M. J., G. B. Vogelsang, R. A. Beveridge, E. R. Farmer, V. Altomonte, A. M. Huelskamp, and N. E. Davidson. 1993. Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J. Clin. Oncol. 11:484.
7. Kennedy, M. J., G. B. Vogelsang, R. J. Jones, E. R. Farmer, A. D. Hess, V. Altomonte, A. M. Huelskamp, and N. E. Davidson. 1994. Phase I trial of intravenous interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J. Clin. Oncol. 12:249.
8. Cheney, R. T., and J. Sprent. 1985. Capacity of cyclosporine to induce autograft-versus-host disease and impair intrathymic T cell differentiation. Transplant Proc. 17:528.
9. Bryson, J. S., C. D. Jennings, B. E. Caywood, and A. M. Kaplan. 1989. Induction of a syngeneic graft-versus-host disease-like syndrome in DBA/2 mice. Transplantation 48:1042.
10. Bucy, R. P., X. Y. Xu, J. Li, and G. Q. Huang. 1993. Cyclosporine-A-induced autoimmune disease in mice. J. Immunol. 151:1039.
11. Sorokin, R., H. Kimura, K. Schroder, D. H. Wilson, and D. B. Wilson. 1986. Cyclosporine-induced autoimmunity: conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats. J. Exp. Med. 164:1615.
12. Fischer, A. C., W. E. Beschorner, and A. D. Hess. 1989. Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease. J. Exp. Med. 169:1031.
13. Fischer, A. C., M. K. Laulis, L. Horwitz, W. E. Beschorner, and A. D. Hess. 1989. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. J. Immunol. 143:827.
14. Ryffel, B., R. Deysserroth, and J. F. Borel. 1981. Cyclosporin A: effect on the mouse thymus. Agents Actions Suppl. 11:373.
15. Beschorner, W. E., J. D. Namnoum, A. D. Hess, C. Shinn, and G. W. Santo. 1987. Cyclosporin A and the thymus: immunopathology. Am. J. Pathol. 126:487.
16. Hess, A. D., L. Horwitz, W. E. Beschorner, and G. W. Santos. 1985. Development of graft-versus-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity. J. Exp. Med. 161:718.
17. Bryson, J. S., B. E. Caywood, and A. M. Kaplan. 1991. Relationship of cyclosporine A-mediated inhibition of clonal deletion and development of syngeneic graft-versus-host disease. J. Immunol. 147:391.
18. + T lymphocyte subsets. J. Immunol. 140:526.
19. Bos, G. M. J., G. C. Majoor, and P. J. C. Van Breda Briesman. 1988. Cyclosporin A induces a selective, reversible suppression of T-helper lymphocyte regeneration after syngeneic bone marrow transplantation: association with syngeneic graft-versus-host disease in rats. Clin. Exp. Immunol. 74:443.
20. Hess, A. D., E. C. Bright, C. Thoburn, G. B. Vogelsang, R. J. Jones, and M. J. Kennedy. 1997. Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide. Blood 89:2203.
21. Antin, J. H., and J. L. M. Ferrara. 1992. Cytokine dysregulation and acute graft-versus-host disease. Blood 80:2964.
22. Allen, R., T. A. Staley, and C. L. Sidman. 1993. Differential cytokine expression in acute and chronic graft-versus-host disease. Eur. J. Immunol. 23:333.
23. Rus, V., A. Svetic, P. Nguyen, W. C. Gause, and C. S. Via. 1995. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. J. Immunol. 155:2396.
24. Via, C. S., V. Rus, M. K. Gately, and F. D. Finkelman. 1994. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J. Immunol. 153:4040.
25. Williamson, E., P. Garside, J. A. Bradley, and A. M. Mowat. 1996. IL-12 is a central mediator of acute graft-versus-host disease in mice. J. Immunol. 157:689.
26. Sykes, M., G. L. Szot, P. L. Nguyen, and D. A. Pearson. 1995. Interleukin-12 inhibits murine graft-versus-host disease. Blood 86:2429.
27. + helper cells. Transplantation 60:481.
28. Brok, H. P. M., D. J. Heich, P. H. Van der Meide, C. Zurcher, and J. M. Vossen. 1993. Interferon-γ prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J. Immunol. 151:6451.
29. Seder, R. A., B. L. Kelsall, and D. Jankovic. 1996. Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J. Immunol. 157:2745.
30. + bone marrow cells regulate the induction of murine syngeneic graft-versus-host disease. Transplantation 56:941.
31. Bryson, J. S., C. D. Jennings, B. E. Caywood, D. M. Lowery, S. L. Carlson, D. L. Pflugh, B. E. Caywood, and A. M. Kaplan. 1999. Rejection of an MHC class II negative tumor following induction of murine syngeneic graft-versus-host disease. Bone Marrow Transplant. 23:363.
32. Murphy, T. L., M. G. Cleveland, P. Kulesza, J. Magram, and K. M. Murphy. 1995. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell Biol. 15:5258.
33. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.
34. Brunda, M. J. 1994. Interleukin-12. J. Leukocyte Biol. 55:280.
35. Kichian, K., F. P. Nestel, D. Kim, P. Ponka, and W. S. Lapp. 1996. IL-12p40 messenger RNA expression in target organs during acute graft-versus-host disease. J. Immunol. 157:2851.
36. Bryson, J. S., C. D. Jennings, B. E. Caywood, and A. M. Kaplan. 1990. Strain specificity in the induction of syngeneic graft-versus-host disease in mice. Transplantation 51:911.
37. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008.
38. Hendrzak, J. A., and M. J. Brunda. 1995. Biology of disease. Interleukin-12: biologic activity, therapeutic utility, and role in disease. Lab. Invest. 72:619.
39. Kosugi, A., and G. M. Shearer. 1992. Effect of cyclosporine A on lymphopoiesis. III. Augmentation of the generation of natural killer cells in bone marrow transplanted mice treated with cyclosporine A. J. Immunol. 146:1416.
40. Kuhn, R., J. Lohler, D. Rennick, K. Rajewski, and W. Muller. 1993. IL-10 deficient mice develop chronic enteritis. Cell 75:263.
41. -l- mice: an overview. J. Leukocyte Biol. 61:389.
42. Sadlack, B., H. Merz, H. Schorle, A. Schimpi, A. C. Fleller, and I. Gorak. 1993. Ulcerative colitis-like disease in mice with a disruptive interleukin-2 gene. Cell 75:253.
43. Ehrhardt, R. O., B. R. Ludviksson, B. Gray, M. Neurath, and W. Strober. 1997. Induction and prevention of colonic inflammation in IL-2-deficient mice. J. Immunol. 158:566.
44. Bryson, J. S., H. Lake-Bullock, D. L. Pflugh, C. D. Jennings, P. M. Stuart, B. E. Caywood, and A. M. Kaplan. 1995. In vivo reactivity of T cell clones isolated from mice with syngeneic graft-versus-host disease. Transplantation 60:171.